Pages that link to "Q28248700"
Jump to navigation
Jump to search
The following pages link to Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene (Q28248700):
Displaying 50 items.
- UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients (Q24806179) (← links)
- Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method (Q28143359) (← links)
- FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity (Q28179104) (← links)
- Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism (Q28191057) (← links)
- UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells (Q28248233) (← links)
- Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium (Q28303858) (← links)
- Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein (Q28369530) (← links)
- Molecular cloning, expression and characterization of a monkey steroid UDP-glucuronosyltransferase, UGT2B19, that conjugates testosterone (Q30629555) (← links)
- Characterization of UDP-glucuronosyltransferases active on steroid hormones (Q30741702) (← links)
- Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases (Q33639755) (← links)
- Functional glycosylation in the human and mammalian uterus (Q33654727) (← links)
- Glucuronidation in humans. Pharmacogenetic and developmental aspects (Q33700129) (← links)
- UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility (Q33714575) (← links)
- The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions (Q33724160) (← links)
- Structural and functional studies of UDP-glucuronosyltransferases (Q33781188) (← links)
- Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases (Q33864902) (← links)
- Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk (Q33954754) (← links)
- Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15 (Q34067581) (← links)
- Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance. (Q34093111) (← links)
- Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions (Q34129215) (← links)
- A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation (Q34350941) (← links)
- Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels (Q34556225) (← links)
- Human hepatic UGT2B15 developmental expression (Q34737080) (← links)
- Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients (Q34951367) (← links)
- Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy (Q35008045) (← links)
- UGT genomic diversity: beyond gene duplication (Q35009521) (← links)
- The biochemistry and medical significance of the flavonoids (Q35009698) (← links)
- Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation. (Q35027930) (← links)
- Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. (Q35035611) (← links)
- Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study (Q35051456) (← links)
- Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes (Q35058455) (← links)
- Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry (Q35078297) (← links)
- Pharmacogenomics of human UDP-glucuronosyltransferase enzymes (Q35157993) (← links)
- UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables (Q35187897) (← links)
- Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors (Q35204531) (← links)
- The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation (Q35207750) (← links)
- Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer (Q35749331) (← links)
- Androgens and doping tests: genetic variation and pit-falls (Q36087942) (← links)
- Protein kinase Cα and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity (Q36097980) (← links)
- Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis (Q36367643) (← links)
- A human minor histocompatibility antigen resulting from differential expression due to a gene deletion (Q36370375) (← links)
- Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer (Q36426780) (← links)
- Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancy (Q36469802) (← links)
- Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk (Q36476775) (← links)
- The role of genetic variability in drug metabolism pathways in breast cancer prognosis (Q36497088) (← links)
- Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study (Q36729040) (← links)
- Copy Number Variation of UGT 2B Genes in Indian Families Using Whole Genome Scans (Q36764660) (← links)
- Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone Metabolism. (Q36955916) (← links)
- Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen (Q37221922) (← links)
- Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes (Q37378051) (← links)